Chimigen HBV vaccine (Akshaya Bio)

N/A

Report date: 2025/01/26 18:21:25

Base Information

Drug NameChimigen HBV vaccine (Akshaya Bio)

Drug Alias NameChimigen HBV vaccine (Nuron Biotech)NU-500

ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Antibody fragmentVaccines > Application > Therapeutic vaccineBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Monoclonal antibody murine +[4]

Mechanisms of ActionImmunomodulators

TargetsNot applicable

Therapy Area/IndicationsHepatitis B

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryCanadaUnited States

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaN/A

Originator CompaniesAkshaya Bio Inc

China Registration ClassN/A

Develop Information

Active CompaniesAkshaya Bio Inc

Inactive CompaniesNuron Biotech Inc

Active IndicationsHepatitis B

Inactive IndicationsN/A

Other Information

ATC CodeN/A